Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder - PubMed (original) (raw)
Case Reports
. 1995 Feb:118 ( Pt 1):61-73.
doi: 10.1093/brain/118.1.61.
Affiliations
- PMID: 7895015
- DOI: 10.1093/brain/118.1.61
Case Reports
Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder
I E Scheffer et al. Brain. 1995 Feb.
Abstract
The disorder of autosomal dominant nocturnal frontal lobe epilepsy has recently been identified, and is now delineated in detail. A phenotypically homogeneous group of five families from Australia, Britain and Canada, containing 47 affected individuals, was studied. The largest family contained 25 affected individuals spanning six generations. This disorder is characterized by clusters of brief nocturnal motor seizures, with hyperkinetic or tonic manifestations. Subjects often experienced an aura, and remained aware throughout the attacks. Seizures occurred in clusters (mean eight attacks/night) typically as the individual dozed, or shortly before awakening. The epilepsy usually began in childhood, and persisted through adult life, with considerable intra-family variation in severity. Seizures were often misdiagnosed as benign nocturnal parasomnias, psychiatric and medical disorders. Interictal EEG studies were unhelpful. Ictal video-EEG studies showed that the attacks were partial seizures with frontal lobe seizure semiology. Neuro-imaging was normal. Carbamazepine monotherapy was frequently effective. This disorder showed autosomal dominant inheritance. Recognition of this entity is clinically important for diagnosis, appropriate therapy and genetic counselling. Moreover, this disorder now offers an opportunity to identify a gene for partial epilepsy.
Similar articles
- Autosomal dominant nocturnal frontal lobe epilepsy: an electroclinical study of a Norwegian family with ten affected members.
Nakken KO, Magnusson A, Steinlein OK. Nakken KO, et al. Epilepsia. 1999 Jan;40(1):88-92. doi: 10.1111/j.1528-1157.1999.tb01993.x. Epilepsia. 1999. PMID: 9924907 - [Autosomal dominant nocturnal frontal lobe epilepsy].
Thomas P, Picard F, Hirsch E, Chatel M, Marescaux C. Thomas P, et al. Rev Neurol (Paris). 1998 Apr;154(3):228-35. Rev Neurol (Paris). 1998. PMID: 9773047 French. - Autosomal dominant nocturnal frontal lobe epilepsy: electroclinical picture.
Oldani A, Zucconi M, Ferini-Strambi L, Bizzozero D, Smirne S. Oldani A, et al. Epilepsia. 1996 Oct;37(10):964-76. doi: 10.1111/j.1528-1157.1996.tb00534.x. Epilepsia. 1996. PMID: 8822695 - [Autosomal dominant nocturnal frontal lobe epilepsy: the syndrome].
Picard F, Chauvel P. Picard F, et al. Rev Neurol (Paris). 1999 Jul;155(6-7):445-9. Rev Neurol (Paris). 1999. PMID: 10472656 Review. French. - Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder.
Scheffer IE, Bhatia KP, Lopes-Cendes I, Fish DR, Marsden CD, Andermann F, Andermann E, Desbiens R, Cendes F, Manson JI, et al. Scheffer IE, et al. Lancet. 1994 Feb 26;343(8896):515-7. doi: 10.1016/s0140-6736(94)91463-x. Lancet. 1994. PMID: 7906762 Review.
Cited by
- Nocturnal Frontal Lobe Epilepsy vs Parasomnias.
Derry C. Derry C. Curr Treat Options Neurol. 2012 Oct;14(5):451-63. doi: 10.1007/s11940-012-0191-8. Curr Treat Options Neurol. 2012. PMID: 22865379 - Sleep and seizure risk in epilepsy: bed and wake times are more important than sleep duration.
Stirling RE, Hidajat CM, Grayden DB, D'Souza WJ, Naim-Feil J, Dell KL, Schneider LD, Nurse E, Freestone D, Cook MJ, Karoly PJ. Stirling RE, et al. Brain. 2023 Jul 3;146(7):2803-2813. doi: 10.1093/brain/awac476. Brain. 2023. PMID: 36511881 Free PMC article. - Therapy in Sleep-Related Hypermotor Epilepsy (SHE).
Asioli GM, Rossi S, Bisulli F, Licchetta L, Tinuper P, Provini F. Asioli GM, et al. Curr Treat Options Neurol. 2020 Jan 30;22(1):1. doi: 10.1007/s11940-020-0610-1. Curr Treat Options Neurol. 2020. PMID: 31997091 Review. - Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy.
Heron SE, Smith KR, Bahlo M, Nobili L, Kahana E, Licchetta L, Oliver KL, Mazarib A, Afawi Z, Korczyn A, Plazzi G, Petrou S, Berkovic SF, Scheffer IE, Dibbens LM. Heron SE, et al. Nat Genet. 2012 Nov;44(11):1188-90. doi: 10.1038/ng.2440. Epub 2012 Oct 21. Nat Genet. 2012. PMID: 23086396 - Mice expressing the ADNFLE valine 287 leucine mutation of the Β2 nicotinic acetylcholine receptor subunit display increased sensitivity to acute nicotine administration and altered presynaptic nicotinic receptor function.
O'Neill HC, Laverty DC, Patzlaff NE, Cohen BN, Fonck C, McKinney S, McIntosh JM, Lindstrom JM, Lester HA, Grady SR, Marks MJ. O'Neill HC, et al. Pharmacol Biochem Behav. 2013 Jan;103(3):603-21. doi: 10.1016/j.pbb.2012.10.014. Epub 2012 Nov 1. Pharmacol Biochem Behav. 2013. PMID: 23123803 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous